Glycemic Control and Hypoglycemia in Patients Treated with Insulin Pump Therapy: An Observational Study

Figure 2

HbA1c levels prior to the beginning of insulin pump therapy (time 0) and during the next months (6 to 54 months). Results are reported as median values and interquartile ranges. In the table, we report the HbA1c level at the beginning of the therapy and its control after the initiation of IPT.